S. Chakrabarti et al., Highly selective isolation of unknown mutations in diverse DNA fragments: Toward new multiplex screening in cancer, CANCER RES, 60(14), 2000, pp. 3732-3737
Cancer research would greatly benefit from technologies that allow simultan
eous screening of several unknown gene mutations. Lack of such methods curr
ently hampers the large-scale detection of genetic alterations in complex D
NA samples. We present a novel mismatch-rapture methodology for the highly
efficient isolation and amplification of mutation-containing DNA from diver
se nucleic acid fragments of unknown sequence. To demonstrate the potential
of this method, heteroduplexes with a single A/G mismatch are formed via c
ross-hybridization of mutant C(T-->G) and wild-type DNA-fragment population
s. Aldehydes are uniquely introduced at the position of mismatched adenines
via the Escherichia coli glycosylase, MutY, Subsequent treatment with a bi
otinylated hydroxylamine results in highly specific and covalent biotinylat
ion of the site of mismatch. For PCR amplification synthetic Linkers are th
en Ligated to the DNA fragments, Biotinylated DNA is then isolated and PCR
amplified. Mutation-containing DNA fragments can subsequently be sequenced
to identify type and position of mutation. This method correctly detects a
single T-->G transversion introduced into a 7-kb plasmid containing full-le
ngth cDNA from the p53 gene, In the presence of a high excess wild-type DNA
(1:1000 mutant:normal plasmids) or in the presence of diverse DNA fragment
sizes, the DNA fragments containing the mutation are readily detectable an
d can be isolated and amplified, The present Aldehyde-Linker-Based Ultrasen
sitive Mismatch Scanning has a current limit of detection of one base subst
itution in 7 Mb of DNA and increases the Limit for unknown mutation scannin
g by two to three orders of magnitude. Homozygous and heterozygous p53 regi
ons (G-->T, exon 4) from genomic DNA are also examined, and correct identif
ication of mutations is demonstrated. This method should allow large-scale
detection of genetic alterations in cancer samples without any assumption a
s to the genes of interest.